Sign up
All pulmonology trends
RisingPulmonology · updated 18 Oct 2026

Bronchiectasis

Non-cystic fibrosis bronchiectasis and its newer treatments.

66PubDaily Trend Score
+35%new papers vs last year
62new trials registered
11new guidelines this year

Papers per year

Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 30, 45, 56, 65, 62.

New guidelines and consensus this year

  1. Management of Adult Bronchiectasis: An American College of Chest Physicians Clinical Practice Guideline
    Chest2026 Oct
  2. Spanish Clinical Practice Guidelines for the Diagnosis and Management of Alpha-1 Antitrypsin Deficiency: 2026 Update
    Arch Bronconeumol2026 Jun 13
  3. The European respiratory society guideline for adult bronchiectasis 2025: summary and implementation guide for primary care
    NPJ Prim Care Respir Med2026 Jun 8
  4. [Guidelines for the diagnosis and treatment of tracheobronchial tuberculosis (2025 Edition)]
    Zhonghua Jie He He Hu Xi Za Zhi2026 May 12
  5. Structure of a Bronchiectasis and Nontuberculous Mycobacteria Care Center: A Position Statement by the Bronchiectasis & NTM Association
    Chest2026 May

All papers from the last 12 months

1,269 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…

Open this search in PubMed
  1. Health utilities in individuals with alpha-1 antitrypsin deficiency with and without COPD from the EARCO registry
    Pulmonology2026 DecPMID 42841174
  2. 'Life has become a lot easier'-the acceptability of the treatable traits clinic experience to people with bronchiectasis
    Ann Med2026 DecPMID 42839548Clinical trial
  3. Patient-Reported Outcome scale for Bronchiectasis (BE-PRO): development and validation in China
    Ann Med2026 DecPMID 42834751
  4. A pilot study to assess the role of 12-week roflumilast treatment in non-CF bronchiectasis
    Pulmonology2026 DecPMID 42821483
  5. Mounier-Kuhn syndrome incidentally diagnosed during the evaluation of atypical chest pain: CT findings and diagnostic challenges
    Radiol Case Rep2026 DecPMID 42781266
  6. Fatigue in bronchiectasis: An under-recognised treatable trait
    Pulmonology2026 DecPMID 42751816
  7. Prevotella intermedia culture supernatant impairs alveolar macrophage function and promotes Mycobacterium avium persistence
    Virulence2026 DecPMID 42745449
  8. Commentary on "prognostic implications of cluster-defined phenotypes in AECOPD patients with bronchiectasis: A multicenter study."
    Pulmonology2026 DecPMID 42740614
  9. Sputum microbiome and clinical profiles in Portuguese non-cystic fibrosis bronchiectasis patients
    Pulmonology2026 DecPMID 42733323
  10. Primary Ciliary Dyskinesia: Insights from a Portuguese tertiary centre cohort
    Pulmonology2026 DecPMID 42478199

More pulmonology trends

All specialties →

New treatments for sleep apnoea

Rising fast
+40%new papersScore 85
20212026

Tirzepatide, hypoglossal nerve stimulation and drug therapy for obstructive sleep apnoea.

Key point: Pharmacological therapy is not routine OSA treatment; dual GIP/GLP-1 agonists such as tirzepatide may be considered adjunctively for obese moderate-to-severe OSA.

253 papers / yr24 new trials5 new guidelines
See all papers →

High-flow nasal oxygen

Rising
+31%new papersScore 71
20212026

High-flow nasal oxygen in acute hypoxaemic respiratory failure.

Key point: HFNC is strongly recommended for adults with acute hypoxemic respiratory failure, with close monitoring for escalation, based primarily on reduced need for intubation.

237 papers / yr44 new trials3 new guidelines
See all papers →

Biologics in COPD

Rising
+66%new papersScore 68
20212026

Dupilumab and other biologics for COPD with type 2 inflammation.

Key point: Pooled analyses suggest dupilumab and mepolizumab consistently reduce moderate-to-severe exacerbations in eosinophilic or type 2 inflammatory COPD.

421 papers / yr38 new trials2 new guidelines
See all papers →

Robotic and navigational bronchoscopy

Rising
+81%new papersScore 64
20212026

Robotic and navigation bronchoscopy to biopsy peripheral lung nodules.

188 papers / yr20 new trials1 new guideline
See all papers →

Antifibrotics in pulmonary fibrosis

Rising
+18%new papersScore 64
20212026

Nintedanib, pirfenidone and newer antifibrotics.

511 papers / yr23 new trials1 new guideline
See all papers →

Biologics in severe asthma

Rising
+23%new papersScore 58
20212026

Biologic therapies for severe asthma.

Key point: Biologic choice in adult severe asthma can be impacted by quality of life impairment, lung function, exacerbation frequency, oral corticosteroid use, endotype, biomarkers and comorbidities.

615 papers / yr18 new trials4 new guidelines
See all papers →

Too many papers to read?

PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.

Get started
How these numbers are counted

PubMed query, searched in titles and abstracts by publication date:

bronchiectasis[tiab]

Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.